Published • loading... • Updated
New Jeffrey Epstein email reveals inquiry about 'zombie drug' known to erase memory and free will
Epstein's emails reveal interest in Angel's Trumpet plants that produce scopolamine, a drug linked to victim symptoms, though no evidence confirms its use in abuse cases.
- On Tuesday, February 17, 2026, the DOJ release shows Jeffrey Epstein, convicted sex offender, emailed asking about his `trumpet plants at nursery` in the Epstein Files declassified tranche.
- The broader DOJ file dump contains victim impact narratives in recent weeks referencing scopolamine and describing memory gaps, confusion, and inability to resist or recall events.
- Medical and forensic notes show scopolamine blocks acetylcholine receptors, causing hallucinations, severe memory loss, and respiratory failure; Angel's Trumpet produces scopolamine, atropine and hyoscyamine, and scopolamine can evade standard forensic toxicology screens.
- Investigators note the documents do not establish that Epstein administered the drug, and forensic experts say standard toxicology can miss scopolamine, leaving the investigation uncertain.
- Despite being a small part of the archive, the Angel's Trumpet emails struck differently as experts stress growing this toxic ornamental is legal, though tabloids and social media label it a `zombie drug` or `Devil's Breath`.
Insights by Ground AI
13 Articles
13 Articles
Epstein's Emails Reveal Interest in Toxic 'Trumpet Plants'
Buried in several hundred pages of newly declassified government paperwork is an email, not long, in which Jeffrey Epstein asks a contact about his 'trumpet plants at nursery.' That is the full quote. No elaboration. No context for why a convicted sex offender was cultivating Angel's Trumpet, a species whose flowers hang like bells and whose every part — roots, stems, leaves, petals — contains enough tropane alkaloids to hospitalise or kill a pe…
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources13
Leaning Left4Leaning Right3Center2Last UpdatedBias Distribution45% Left
Bias Distribution
- 45% of the sources lean Left
45% Left
L 45%
C 22%
R 33%
Factuality
To view factuality data please Upgrade to Premium









